These final results, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the idea of targeting ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated Diseases. Note: Benefits may perhaps https://elenar825lrd3.weblogco.com/profile